0001842952-22-000059.txt : 20220603
0001842952-22-000059.hdr.sgml : 20220603
20220603161028
ACCESSION NUMBER: 0001842952-22-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220602
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kantoff Philip W.
CENTRAL INDEX KEY: 0001866025
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40654
FILM NUMBER: 22994467
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Context Therapeutics Inc.
CENTRAL INDEX KEY: 0001842952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863738787
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 267-225-7416
MAIL ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: Context Therapeutics LLC
DATE OF NAME CHANGE: 20210128
4
1
wf-form4_165428700930146.xml
FORM 4
X0306
4
2022-06-02
0
0001842952
Context Therapeutics Inc.
CNTX
0001866025
Kantoff Philip W.
2001 MARKET STREET
SUITE 3915, UNIT #15
PHILADELPHIA
PA
19103
1
0
0
0
Stock Option (right to buy)
2.19
2022-06-02
4
A
0
25000
0
A
2032-06-01
Common Stock
25000.0
25000
D
1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer.
/s/ Alex Levit, Attorney-in-Fact
2022-06-03